TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

18.50$ +3.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow OMER
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-299.1%
-35.9% +43.5% +83.7% +74.6% +86.1% -9.7% -14.2% -31.3% -3.4% +3.3% +1.5%
+7.4% +41.8% -6.6% -7.7% +17.7% +8.3% +18.1% -20.2% -17.2% -9.9% -21.9%
+13.5% +72.8% -18.2% +5.3% -22.4% +24.2% -1,810.5%
-147.2% -109.2% -286.0% -88.0% +13.4%
+757.1% -47.5% +177.8% +62.0% -41.1% -15.3% -2.1% -59.2% +277.0% -61.3% -60.6%
-434.7% -20.7% +130.2% -113.5% +1,870.9% -165.9% +199.5% +100.1%
+117.0% -49.7% +83.1% -91.1% +818.5% +59.6% -91.8% -94.9% -1,221.4% +154.6% -100.0%
-57.4% +462.4% -101.6% -98.7% +6,331.0% -99.7% -86.2% -254,050.0% -59.3% +115.7%
+70.7% -20.9% +9.2% +8.1% -25.1% +187.5% -96.4% +1,866.3% -185.4% -167.1%
-15.0% +36.2% +110.9% -212.6% +1,117.6% -199.4%
-300.5%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?